FDA Class II · Drug · June 24, 2026
Alyacen 7/7/7 recall — Glenmark Pharmaceuticals Inc., USA
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
Official ID D-0588-2026 · Official record ↗